Rockwell Medical (RMTI) Asset Utilization Ratio (2011 - 2026)
Rockwell Medical (RMTI) posted Asset Utilization Ratio of 1.18 for Q1 2026, down 2.22% on a QoQ basis from 1.21 in Q4 2025, and down 31.59% year-over-year from 1.73 in Q1 2025.
Rockwell Medical (RMTI) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Rockwell Medical's Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 1.18 for Q1 2026.
- Quarterly Asset Utilization Ratio fell 31.59% year-over-year to 1.18 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.18 (down 31.59% YoY) and the FY2025 annual result came in at 1.19, down 34.67% from the prior year.
- Asset Utilization Ratio was 1.18 for Q1 2026 at Rockwell Medical, down from 1.21 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.93 in Q2 2023 and bottomed at 1.18 in Q1 2026.
- A 5-year average of 1.57 and a median of 1.65 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 73.27% — and 2026, when it tumbled 31.59%.
- Rockwell Medical's Asset Utilization Ratio stood at 1.44 in 2022, then climbed by 10.5% to 1.6 in 2023, then gained by 9.36% to 1.75 in 2024, then slumped by 30.77% to 1.21 in 2025, then fell by 2.22% to 1.18 in 2026.
- Business Quant data shows RMTI's Asset Utilization Ratio at 1.18 in Q1 2026, 1.21 in Q4 2025, and 1.37 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 1.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 |
| Dec 31, 2025 | 1.21 |
| Sep 30, 2025 | 1.37 |
| Jun 30, 2025 | 1.65 |
| Mar 31, 2025 | 1.73 |
| Dec 31, 2024 | 1.75 |
| Sep 30, 2024 | 1.80 |
| Jun 30, 2024 | 1.82 |
| Mar 31, 2024 | 1.68 |
| Dec 31, 2023 | 1.60 |
| Sep 30, 2023 | 1.78 |
| Jun 30, 2023 | 1.93 |
| Mar 31, 2023 | 1.75 |
| Dec 31, 2022 | 1.44 |
| Sep 30, 2022 | 1.21 |
| Jun 30, 2022 | 1.37 |
| Mar 31, 2022 | 1.46 |
| Dec 31, 2021 | 1.15 |
| Sep 30, 2021 | 1.01 |
| Jun 30, 2021 | 0.92 |